SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001206774-09-000338
Filing Date
2009-02-26
Accepted
2009-02-26 07:30:49
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT regeneron_10k.htm 10-K 1129411
2 GRAPHIC regeneron_10k4x4x1.jpg GRAPHIC 41472
3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF NOVEMBER 14, 2008 exhibit10-3.htm EX-10.3 119652
4 REGENERON PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE PLAN exhibit10-5.htm EX-10.5 103368
5 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGES exhibit12-1.htm EX-12.1 28185
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP exhibit23-1.htm EX-23.1 1746
7 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) exhibit31-1.htm EX-31.1 8511
8 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) exhibit31-2.htm EX-31.2 8941
9 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 exhibit32.htm EX-32 3364
  Complete submission text file 0001206774-09-000338.txt   1461777
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19034 | Film No.: 09635585
SIC: 2834 Pharmaceutical Preparations